PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: DNA Diagnostics Centre

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DNA Diagnostics Centre Now Analyse 22 Genetic Markets for All STR Testing Services - DDC, increases the Identification Power of its DNA Tests by more than 500%. DDC (DNA Diagnostics Centre) will now analyse 22 genetic markets for all STR testing services - DNA-Bioscience.co.uk / DNAcenter.com
DNA Diagnostics Centre Now Analyse 22 Genetic Markets for All STR Testing Services

 

NewswireToday - /newswire/ - London, United Kingdom, 2013/10/24 - DDC, increases the Identification Power of its DNA Tests by more than 500%. DDC (DNA Diagnostics Centre) will now analyse 22 genetic markets for all STR testing services - DNA-Bioscience.co.uk / DNAcenter.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

DDC (DNA Diagnostics Centre) and it’s division, DDC Medical, one of the world’s largest providers of DNA tests, announced today that all DNA tests utilising Short Tandem Repeat (STR) DNA testing technology, including Paternity and Cell Line Authentication testing, will now examine 22 genetic markers versus 17, which until today has been the core standard in the industry.

With the increase in the number of genetic markers used to create unique DNA profiles, DDC and DDC Medical remain at the forefront of human relationship and cell identity testing. The company continues to lead the industry by introducing this upgraded capability at no additional cost or turn-around time to the consumer. Dr. Michael Baird, DDC’s Chief Science Officer and one of the first experts to cite DNA in a court of law, says,“This exciting change in our protocol increases DDC’s power of a unique DNA signature by more than 5 fold. By including these additional markers, we continue to provide the most comprehensive test battery available for human identification.”

About Dr. Baird
Dr. Michael Baird, Chief Science Officer of DDC, is considered one of the world’s foremost experts in DNA and paternity testing, and was the first person to testify in a criminal DNA case in the US, and since 1987, has been involved in more than 350 court cases involving DNA and paternity. He is currently the Chair of the Relationship Testing Committee of the AABB responsible for developing standards for paternity testing. Dr. Baird has authored or coauthored over 50 peer reviewed scientific articles involving DNA identification analysis. He has served as an on-air consultant to NBC, CNN, MSNBC, Fox News and many of the world’s leading news outlets. Dr. Baird received his BA in Biology from Drew University in 1971, his MA in Biology from the State University of New York in 1973, and earned his PhD in Genetics from the University of Chicago in 1978. He was a postdoctoral fellow at the University of Michigan in the department of human genetics where he studied sickle cell anemia, followed by a position as a Research Associate at Columbia University in the department of human genetics. Dr. Baird served on the panel of the Office of Technology Assessment for the U.S. Congress studying the use of DNA for identification. He also presented information to the panels of the National Research Council that studied DNA testing methods and issued reports in 1992 and 1996.

About DNA Diagnostics Center (DDC)

DDC (dnacenter.com) is one of the world’s largest DNA testing companies. Founded 19 years ago, DDC offers comprehensive DNA testing services for paternity and other family relationships, forensics, cell line authentication, and ancestry. DDC receives more than 800,000 consumer calls each year and performs over half a million tests annually. The Company is known for its groundbreaking technologies, including an exclusive license for the most innovative and accurate non-invasive prenatal paternity test using SNP (single-nucleotide polymorphism) Microarray Technology, which only requires a simple blood draw from the mother and alleged father. DDC's unique Dual Process™ ensures all professionally collected DNA samples are independently tested twice producing legal results of unmatched quality and reliability. DDC is recognisd through a number of accreditations nationally and internationally achieving perfect ratings in its past 19 inspections including those performed by the (AABB) and (CAP). DDC is also accredited by ACLASS to meet the standards of ISO 17025:2005 and the American Society of Crime Laboratory Directors Laboratory Accreditation Board International and follows the DNA Advisory Board (DAB) guidelines, which attests to DDC's superior forensic testing service. DDC is also accredited by the Ministry of Justice. For more information call 0800 321 7016.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: DNA Diagnostics Centre

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


DNA Diagnostics Centre Now Analyse 22 Genetic Markets for All STR Testing Services

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Dan Leigh - DNAcenter.com 
0800 860 0856 dleigh[.]dnacenter.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any DNA Diagnostics Centre securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From DNA Diagnostics Centre / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)